Answers are grounded in this paper and cite their sources.
To the Editor: The New Delhi metallo-β-lactamase (NDM-1) was fi rst characterized in 2009 from Klebsiella pneumoniae and Escherichia coli isolated from a patient in Sweden who had received medical care in New Delhi, India (1).Further studies have shown broad dissemination of this β-lactamase gene (bla NDM-1 ) in India, Pakistan, Bangladesh, and the United Kingdom (2).Additional isolates have been detected in other countries, and many of the patients with NDM-1producing Enterobacteriaceae reported receiving medical care in the Indian subcontinent (1-7).We describe detection and characterization of an NDM-1-producing K. pneumoniae isolated in Ontario, Canada.In August 2010, a urinary tract infection was diagnosed in a 36-yearold woman in a hospital in Brampton, Ontario.An E. coli strain sensitive to multiple antibacterial drugs (including carbapenems) was isolated from a midstream urine sample; the patient was successfully treated with ciprofl oxacin.One week after treatment, when the patient did not have a fever or other clinical signs, a urine culture was repeated, and a carbapenem-resistant K. pneumoniae isolate (GN529) was recovered.Travel history indicated that the patient had recently returned from India, where in mid-July she had had a miscarriage and had been hospitalized in Mumbai for 2 days.At that time, no antimicrobial drug treatment was prescribed.Susceptibility profi les of K. pneumoniae GN529 and its E. coli transconjugant were obtained by using Etest (bioMérieux, Marcy l'Etoile, France) and the agar dilution method based on the Clinical and Laboratory Standards Institute guidelines (8).Multilocus sequence typing (MLST) of isolate GN529 was performed as described
No takes yet. Share an insight, caveat, or question.
Tijet et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: